Sickle cell anaemia is a genetic blood disorder characterised by the production of an abnormal haemoglobin, known as haemoglobin S. Sickle cell disease changes the shape of blood cells into a crescent ...
The chronic nature of Sickle Cell Disease and its impact on various organs ... For example, when dealing with a complication such as a leg ulcer, frequent hospital visits for wound dressing ...
We can do better. We can build a system that provides coordinated high-quality care to every patient who needs it.
With sickle cell disease, pain is often ever-present ... Pain may be caused by various complications of the disease, such as leg ulcers, avascular necrosis, chronic pain syndrome, chronic fatigue ...
Sickle cell disease is the name for a group of inherited ... if you suddenly develop severe abdominal pain. These are painful ulcers that grow in the lining of the stomach causing a gnawing ...
Sickle cell disease encompasses a range of inherited ... and nausea. Stomach ulcers occur when damage is inflicted on the protective layer of the stomach lining against stomach acids.
Some of the major conditions that cause this form of the disease are outlined below ... should be reported to their healthcare team. Sickle cell anemia is a genetic form of anemia, and patients ...
What is Oxbryta for sickle cell disease? Oxbryta (voxelotor), which is now withdrawn ... Oxbryta was deemed generally safe and well tolerated and also helped heal painful leg ulcers, a common ...
written by Débora Frauches, Julia da Silva Gonçalves dos Santos, Renata Lanziani, Águeda Glória Sabino de Matos, André Baima, Ana Maria Mach Queiroz, Eleonora D’Ávila Thomé, Karen Cordovil, ...
Our fundamental challenge is not simply to create the data. Rather, it is to collect and analyze it systematically. Doing so ...
A sickle cell disease “cure” is to be offered to NHS patients for the first time. The £1.65 million gene therapy called exa-cel, also known under the brand name Casgevy, uses a Nobel Prize ...
A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...